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A B S T R A C T
Background: Tuberculous meningitis (TBM) and herpes simplex encephalitis (HSE) are common
neurological diseases involving the brain parenchyma, and both can result in chronic epilepsy. Here, we
identiﬁed possible variables affecting the prognosis of central nervous system (CNS) infection-related
epilepsy.
Methods: The clinical seizure characteristics and demographic data of 20 TBM- and 55 HSE-related
epilepsy patients were compared. Statistically signiﬁcant prognostic variables were identiﬁed using
multiple regression analysis.
Results: Sex, age at infection, age at epilepsy onset, presence of seizures at the time of infection, latency
period, and seizure characteristics between two groups were similar except for the pattern of brain
lesions observed on the MRI and their overall prognosis. Patients with hippocampal sclerosis (HS) only
comprised 30% and 52.7% of the TBM and HSE groups, respectively. Encephalomalacia had a positive
effect in the HSE group while HS had a negative effect in this group, but no signiﬁcant effects were found
in the TBM group. Through a multiple regression analysis with a correction for group effects, HS was
associated with a poor prognosis. However, encephalomalacia was concomitantly associated with a good
prognosis. In addition, a short latency period, with a one-year interval, and being male were both
associated with a good prognosis, while the age at the onset of epilepsy was associated with a poor
prognosis.
Conclusions: This study suggests that HS and encephalomalacia could have mutual but contradictory
effects on the prognosis of CNS infection-related epilepsy.
 2011 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Any central nervous system (CNS) infection affecting the brain
parenchyma can result in epilepsy as a chronic sequela as well as
acute seizures at the time of infection. Tuberculous meningitis
(TBM) is the most frequent and severe manifestation of CNS
involvement during tuberculosis, and herpes type 1 encephalitis is
the most common cause of sporadic viral encephalitis worldwide.
An epidemiologic study on all types of encephalitis based on 20-
year follow-up reported chronic epilepsy in 22% of patients who
experienced seizures during acute encephalitis.1 Chronic epilepsy
as a sequela of CNS infection in TBM occurs in more than 20% of
cases.2,3 In cases of herpes simplex encephalitis (HSE), 16–24% of
survivors are known to develop epilepsy.1,4
CNS infection is one of the multi-factorial aetiologies of
epilepsy; however, CNS infection-related epilepsy has not been
studied in detail, especially in terms of prognosis and prognostic* Corresponding author. Tel.: +82 2 2228 1606; fax: +82 2 393 0705.
E-mail address: scpark@yuhs.ac (S. Park).
1059-1311/$ – see front matter  2011 British Epilepsy Association. Published by Else
doi:10.1016/j.seizure.2011.04.007factors. Importantly, previous studies have predominantly exam-
ined patients with CNS infection,5 not patients with CNS infection-
related epilepsy. In one study investigating catastrophic post-
encephalitic epilepsy,6 the study population was based on surgical
candidates with intractable epilepsy.
This study focused on patients with TBM- and HSE-related
epilepsy. Each patient presented with distinct clinical manifesta-
tions due to the different underlying pathophysiologies, which
result in lesions on the brain parenchyma in speciﬁc locations
depending on the aetiology. These lesions appeared to give rise to
prognostic differences, which prompted us to compare the
demographic data and clinical seizure characteristics of the two
groups. Interestingly, the pattern of brain lesions detected using
MRI and the overall prognosis were statistically signiﬁcant
variables. The distinct patterns of brain lesions underlying the
different inﬂammatory processes are thought to be related to
prognosis in CNS infection-related epilepsy.
Herpes simplex virus type 1 is known to have a predilection for
limbic structures,7 including the temporal lobe. The frequently
observed lesions in this area during acute inﬂammatory processes
result in focal/diffuse atrophy or encephalomalacia. Hippocampalvier Ltd. All rights reserved.
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Studies using experimental models have suggested a common ﬁnal
pathway for seizure generation and propagation in multiple
conditions with various causes.2 We hypothesised that CNS
inﬂammatory processes may work via a common process even
though the underlying pathogen is different and that the resulting
brain lesions may give rise to different prognoses.
Here, we identiﬁed possible variables affecting the prognosis of
CNS infection-related epilepsy. The comparison of the clinical
proﬁles between the patients with TBM- and HSE-related epilepsy
focused on the brain lesions in each group. The clinical variables
affecting prognosis, especially encephalomalacia and HS, were also
statistically analysed. These results will extend our understanding
of CNS infection-related epilepsy.
2. Methods
We retrospectively studied 55 patients with HSE-related
epilepsy and 20 patients with TBM-related epilepsy who were
evaluated between March 1994 and February 2010 at the Yonsei
University Medical Centre. A positive polymerase chain reaction
for herpes simplex virus in the cerebrospinal ﬂuid (CSF), mental
changes concomitant with EEG, and typical CSF proﬁles were
compatible with a diagnosis of HSE. The diagnosis of TBM was
based on positive culture of acid-fast bacilli (AFB) in the CSF, which
was found in 13 patients. A CSF proﬁle with elevated adenosine
deaminase and accompanying evidence of tuberculosis in the body
were also considered in the diagnosis of TBM in AFB-negative
patients. Referred patients were included with documented CSF
proﬁles and positive serological results. CNS infection-related
demographic data, such as sex, age at infection, age at the onset of
epilepsy, presence of seizures at the time of infection, and latency
period from the time of infection to the onset of epilepsy, were
compared between the two groups. The clinical characteristics ofTable 1
Demographic data and clinical proﬁles of the patients with epilepsy.
Clinical variable TBM group (n = 
Demographic data
Sex (M:F) 10:10 
Mean age of infection  SD (range), years. 10.0  12.2 (1–4
Latent period  SD (range), years. 5.3  6.5 (0–22) 
Mean age at epilepsy onset  SD (range), years. 15.2  11.2 (1–4
Presence of seizures at time of infection (%) 7/12a (58.3) 
F/U duration  SD (range), m. 83.8  54.2 (24–
Clinical characteristics of seizure, n (%)
Clinical feature of TLE 12 (60) 
Aura/limbic aura 16 (80)/10 (50) 
Automatism 11 (55) 
Secondary GTC 15 (75) 
Clustering nature 1 (5) 
Nocturnal dominancy 5 (25) 
Pattern of lesion on brain MRI, n (%)
HS only 6 (30) (3 bil.) 
Encephalomalacia only 5 (25) 
Unilobar/multilobar involvement 2/3 
HS with encephalomalacia 7 (35) 
Unilobar/multilobar involvement 3/4 
Normal 2 (10) 
Overall prognosis, n (%)
Good prognosis
Seizure free or aura only 6 (30) 
More than 50% reduction in seizure frequency 6 (30) 
Poor prognosis
Less than 50% reduction in seizure frequency 4 (20) 
No change or aggravation 4 (20) 
NS, nonspeciﬁc signiﬁcance; F/U, follow up; TLE, temporal lobe epilepsy; GTC, generali
a Presence of seizure at the time of infection was unclear in 8 cases in TBM group a
b p- value of Chi-square test between TBM and HSE.
c A simple logistic regression analysis was used to reveal prognostic factors among temporal lobe epilepsy (TLE) such as aura or automatism were
recorded. The general characteristics of the seizures, such as partial
seizure without secondary generalized tonic–clonic (GTC) seizure,
clustering nature, and nocturnal dominance, were analysed.
Nocturnal dominance was deﬁned as more than 90% of habitual
seizures occurring during sleep.
The MRI ﬁndings were reviewed by a neuroradiologist and
the corresponding author, both of whom were blinded to the
diagnosis, and classiﬁed as follows: HS only, HS with encepha-
lomalacia, encephalomalacia only, and normal. Encephalomala-
cia cases were further divided into unilobar and multilobar
involvement depending on the extent of malatic change.
Hemiatrophy or diffuse atrophy of the cortex was regarded as
multilobar involvement. The minimal follow-up duration for
analysis of prognosis was two years. The prognosis of patients
who had undergone epilepsy surgery (three in the TBM group
and nine in the HSE group) was based on a 12-month follow-up
before the surgery. The prognosis was categorized depending on
the reduction in the frequency of seizures: Seizure-free or rare
aura only; more than a 50% reduction; less than a 50% reduction;
and no change or aggravation. The prognosis was also divided
into two groups: patients with no seizures or rare aura and more
than a 50% reduction were grouped as ‘‘good’’ prognosis, and
patients with less than a 50% reduction and no change or
aggravation were grouped as ‘‘poor’’ prognosis. A statistical
comparison of the clinical proﬁles between the TBM and HSE
groups was conducted using the Chi-square test, and variables
with prognostic signiﬁcance were then analysed using simple
logistic regression. The latter criteria for the prognosis were
used for statistical analysis. Multiple logistic regression tests,
depending on the signiﬁcant covariate, were conducted to
identify prognostic factors in each group and in all patients,
regardless of disease type. SAS software (version 9.1.3) was used
for the statistical analyses.20) HSE group (n = 55) p valueb,c
34:21 NS/0.03
0) 15.4  18.8 (0.1–68) NS/NS
5.0  6.9 (0–34) NS/0.01
0) 20.3  17.6 (1–69) NS/0.08
39/47a (83%) NS/NS
192) 109.5  79.6 (24–204)
35 (63.6) NS/NS
34 (61.8)/14 925.5) NS/NS
33 (60) NS/NS
40 (72.7) NS/NS
9 (16.4) NS/NS
5 (9.1) NS/NS
29 (52.7) (10 bil.)
6 (10.0)
3/3
20 (36.4)
6/14
0
13 (23.6)
4 (7.3)
17 (30.9)
21 (38.2)
zed tonic–clonic seizure; bil., bilateral.
nd in 8 cases in HES group.
all patients.
Table 3
Prognosis depending on encephalomalacia irrespective of HS.
Good Pn.a Poor Pn.b p valuec p valued
TBM group NS
With encephalomalacia (n = 12) 9 3
Without encephalomalacia (n = 8) 3 5
HSE group NS 0.02
With encephalomalacia (n = 26) 11 15
Without encephalomalacia (n = 29) 6 23
Pn, prognosis; NS, nonspeciﬁc signiﬁcance.
a Patients with no seizures or aura only and more than a 50% reduction in seizure
frequency.
b Patients with less than a 50% reduction in seizure frequency and no change or
aggravation.
c Determined using a Chi-square test.
d Determined using a simple logistic regression analysis.
Table 4
Prognosis depending on HS irrespective of encephalomalacia.
Good Pn.a Poor Pn.b p valuec p valued
TBM group NS
With HS (n = 13) 6 7
Without HS (n = 7) 6 1
HSE group NS 0.05
With HS (n = 49) 14 35
Without HS (n = 6) 3 3
Pn, prognosis; NS, nonspeciﬁc signiﬁcance.
a Patients with no seizures or aura only and more than a 50% reduction in seizure
frequency.
b Patients with less than a 50% reduction in seizure frequency and no change or
aggravation.
c Determined using a Chi-square test.
d Determined using a simple logistic regression analysis.
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A Chi-square analysis of the demographic and clinical seizure
characteristics of the subjects did not identify any signiﬁcantly
different variables between the TBM and HSE groups even though
some gross differences were apparent (Table 1). The mean age of
infection was 10.0  12.2 years in the TBM group and 15.4  18.8
years in the HSE group. The mean age at the onset of epilepsy was
15.2  11.2 years in the TBM group and 20.3  17.6 years in the HSE
group, with a latency period of 5.3  6.5 years and 5.0  6.9 years,
respectively. Seizures were present at the time of infection in 58.3% of
the TBM group and 83% of the HSE group. The presence of seizures at
the time of infection was not clearly deﬁned in eight cases in the TBM
group and in eight cases in the HSE group. The clinical features of TLE,
including aura and automatism, secondary generalized TCG, a
clustering nature, and nocturnal dominance, did not differ between
the two groups (Table 1).
Both the prognosis and the brain lesion pattern were
statistically signiﬁcant between the TBM and HSE groups
(p = 0.03 and 0.02, respectively; Chi-square). Patients with HS
only comprised 30% and 52.7% of the TBM and HSE groups,
respectively, and patients with encephalomalacia only comprised
25% and 10% of the TBM and HSE groups, respectively. Multilobar
involvement in the encephalomalacia was observed in 58.3% (7/12)
and 65.4% (17/26) of the TBM and HSE groups, respectively. Four
cases of tuberculoma and two cases of basal ganglia infarction
were noted in the TBM group, and ﬁve cases of hemiatrophy and
two cases of diffuse atrophy were regarded as multilobar
involvement in the HSE group.
When the prognosis was deﬁned as ‘‘good’’ or ‘‘poor’’, 60% of the
TBM and 30.9% of the HSE patients fell into the good prognosis
group, and 40% of the TBM and 69.1% of the HSE patients fell into
the poor prognosis group.
A signiﬁcant correlation between the prognosis and the pattern
of brain lesions was observed in the HSE group, not in the TBM
group. The statistical signiﬁcance was greater when all patients
were analysed irrespective of group (Table 2). These results suggest
that HS and encephalomalacia are the main factors affecting
prognosis. While the prognoses based on encephalomalacia
irrespective of HS or the prognoses based on HS irrespective of
encephalomalacia were not signiﬁcant for each group, a simple
logistic regression analysis determined that encephalomalacia
(p = 0.02) showed more prognostic signiﬁcance than HS (p = 0.057;
Tables 3 and 4). These results demonstrate that the brain lesion
pattern could have prognostic value, regardless of the group.
Using a simple logistic analysis, sex, latency period, and age at
the onset of epilepsy were also determined to be covariates withTable 2
Prognosis depending on the pattern of MRI lesions.
Good Pn.a Poor Pn.b p valuec p valued
TBM group
HS only (n = 6) 1 5
Encephalomalacia only (n = 5) 4 1
HS with encephalomalacia (n = 7) 5 2 NS
Normal (n = 2) 2 0 0.02
HSE group
HS only (n = 29) 6 23
Encephalomalacia only (n = 6) 3 3
HS with encephalomalacia (n = 20) 8 12 0.03
Normal (n = 0) 0 0
Pn, prognosis; NS, nonspeciﬁc signiﬁcance.
a Patients with no seizures or aura only and more than a 50% reduction in seizure
frequency.
b Patients with less than a 50% reduction in seizure frequency and no change or
aggravation.
c Determined using a Chi-square test.
d Determined using a simple logistic regression analysis.prognostic signiﬁcance (Table 1) in which multicollinearity was
veriﬁed. A multiple logistic regression analysis was conducted for
each group and for both groups combined. In the HSE group,
encephalomalacia wad correlated with a positive prognosis
(p = 0.031), while HS was correlated with a negative prognosis
(p = 0.046). No signiﬁcant effects were observed in the TBM group.
When encephalomalacia and HS were considered together,
encephalomalacia was associated with a positive prognosis (odds
ratio = 4.133; 95% CI, 1.144–14.928; p = 0.03), but HS was
associated with a negative prognosis (odds ratio = 0.231; 95% CI,
0.044–1.211; p = 0.08). Among the statistically signiﬁcant covari-
ates, being male showed a positive prognostic effect compared to
being female, and a shorter latency period with a one-year interval
was also associated with a good prognosis (Table 5). However, age
at the onset of epilepsy was associated with a poor prognosis.
4. Discussion
While transient and strictly controlled inﬂammation in the
brain is an adaptive response, chronic, inappropriately controlled
inﬂammation in the brain can become detrimental to neurons andTable 5
Result of the logistic multiple regression analysis when both groups were combined
to correct for the effect of group.
Signiﬁcant covariate Estimatea p value Odds ratio 95% conﬁdence
interval
Encephalomalacia 1.4191 0.0303 4.133 1.144–14.928
HS 1.4659 0.0831 0.231 0.044–1.211
Sex (male) 1.5912 0.0218 4.910 1.261–19.114
Latency period 0.0990 0.0347 1.104 1.007–1.210
Age at the onset of epilepsy 0.0289 0.2250 1.104 1.007–1.210
a Compatible with regression coefﬁcient.
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epileptic activities or by pre-existing brain pathologies.8 A recent
study examining active neuroinﬂammation and marked cellular
injury in the pathology of paediatric epilepsy surgery has
suggested a common pathogenic role or consequence in childhood
epilepsy with diverse aetiologies.9 Although the pathophysiologic
basis of chronic epilepsy following CNS infection is not well known,
reactive gliosis after neuronal damage from changes in the local
cellular and biochemical environmental is thought to be related to
seizure induction. Studies using experimental models have
suggested the likelihood of a common ﬁnal pathway for seizure
generation and propagation in multiple conditions with various
causes.2
Approximately 2% of tuberculosis cases develop TBM,10 and
parenchymal invasion or tuberculoma formation can result in
chronic epilepsy with a latency period. Post-encephalitic ence-
phalomalacia, including HS in limbic structures, the preferred area
in herpes simplex virus type 1 infection, is commonly related to
symptomatic epilepsy.
This study focused on the clinical variables affecting the
prognosis of CNS infection-related epilepsy. A comparison of the
demographic data and the clinical seizure characteristics of the
subjects with TBM and HSE showed no signiﬁcant difference
between the groups, with the exception of the overall prognosis
and the brain lesion pattern apparent following MRI. Interestingly,
the mean latency period was almost the same in the TBM and HSE
groups, with a 5.3-year and 5.0-year latency period, respectively.
The latency period of the TBM group was much shorter than both
the 8.5 years observed in patients with meningitis of unknown
cause11,12 and the 15 years or more in patients with brain
abscesses.12,13 The latency period in our HSE group was similar to
the 4.5 years reported by Lancman and Morris.11 However, the
latency period following of catastrophic post-encephalitic epilepsy
was 0.8 years, during which the majority of patients were referred
for presurgical evaluation. Furthermore, 32 of the 42 patients
showed no latency period from the initial insult to the onset of
recurrent seizures.6 The most important predictive factor for the
development of epilepsy has been reported to be status epilepticus
during encephalitis,14 and acute seizure at the time of infection has
been proposed to be another possible risk factor of later epilepsy.
The overall incidence of acute symptomatic seizure following CNS
infection regardless of the pathogen has been reported to be
23%.1,15 The incidence of acute seizures at the time of acute CNS
infection was highest in HSE with an incidence of 62%16 or 67%17
and in TBM with an incidence of 16.3–31.5%.18,19 While our results
are higher than those previously reported, the reason for this
difference is that all of the subjects in our study were epilepsy
patients, and, in contrast to the above mentioned studies, all were
patients with CNS infection.
Similar to the demographic data, the clinical seizure character-
istics, such as the characteristics of TLE, secondary GTC, a
clustering nature, and nocturnal dominance, were not statistically
different between the two groups. While TBM and HSE had clearly
different symptomatic presentations and clinical progress at the
acute stage due to different underlying pathophysiologies, the lack
of a statistical difference in the epilepsy-related variables between
the two groups suggests that there may be a common pathway for
epileptogenesis that may be related to an inﬂammatory process
during CNS infection, further supporting the aforementioned
hypotheses.2,9 Involvement of the mesial temporal structure
during CNS infection is common and has been reported in 64.3%
of patients who underwent epilepsy surgery following CNS
infection.11 In one study, 13 of the 17 patients with status
epilepticus or repetitive seizure during the acute phase of the
encephalitis were conﬁrmed to have HS.4 Our data in CNS
infection-related epilepsy showed that the involvement of HSalone was 30% and 52.7% in the TBM and HSE groups, respectively,
and in combination with encephalomalacia was 65% and 89.1%,
respectively. The pattern of brain lesions detected using MRI was
different between two groups, but the pattern of lobar encepha-
lomalacia involvement was not appreciably different between the
two groups. In terms of overall prognosis, while the difference
between the two groups was clear, the prognosis depending on the
pattern of brain lesions was only statistically signiﬁcant in the HSE
group. The analysis irrespective of group demonstrated that the
pattern of brain lesions may clearly affect the prognosis of these
two groups.
The statistical analysis showed that encephalomalacia, irre-
spective of the presence of HS, did not signiﬁcantly affect prognosis
in either group. Additionally, HS, irrespective of the presence of
encephalomalacia, did not affect the prognosis in either group.
However, each factor (HS and encephalomalacia) was an indepen-
dent, signiﬁcant prognostic factor when corrected for the group
effect. These results suggest that HS and encephalomalacia could
function as prognostic factors rather than contributing to the
underlying aetiology of CNS infection-related epilepsy. It also
supports the hypothesis that there may be a common pathway for
epileptogenesis related to inﬂammatory processes resulting from
CNS infections.
In addition to HS and encephalomalacia, being male, latency
period, and age at the onset of epilepsy were conﬁrmed as
covariates related to prognosis. A multiple regression analysis
examining sex, latency period, and age at the onset of epilepsy on
each group showed that HS and encephalomalacia could function
as negative and positive prognostic factors in the HSE group,
respectively, but were not signiﬁcant factors in the TBM group.
When the group effect was statistically corrected for, HS had a
negative prognostic effect while encephalomalacia was a positive
prognostic factor. Similarly, while the other covariates could not
function as prognostic factors when groups were analysed
separately, following the correction for the group effect, being
male was found to be a positive prognostic factor. Furthermore, a
shorter latency period was a positive prognostic factor while age at
the onset of epilepsy was a negative prognostic factor.
5. Conclusions
The demographic data and clinical epilepsy characteristics of
subjects with TBM- and HSE-related epilepsy were similar except
for the pattern of brain lesions and overall prognosis. HS and
encephalomalacia may function more as prognostic factors rather
than being simply related to the underlying aetiology of CNS
infection-related epilepsy. These results suggest that there may be
a common pathway for epileptogenesis related to inﬂammatory
processes resulting from CNS infections.
Sex, latency period, and age at the onset of epilepsy were also
independent prognostic factors when the data were corrected for
the group effect. As determined using multiple regression analysis,
encephalomalacia had a positive effect and HS had a negative effect
in the HSE group, but no signiﬁcant effects were found in the TBM
group. When corrected for the group effect, HS was associated with
a poor prognosis while encephalomalacia was associated with a
good prognosis. Along with HS and encephalomalacia, being male
and having a shorter latency period were both associated with a
good prognosis, but age at the onset of epilepsy was negatively
associated with prognosis.
This study suggests that HS and encephalomalacia could have
mutual but contradictory effects on the prognosis of CNS infection-
related epilepsy. Additional, more extensive studies of CNS
infection-related epilepsy with different underlying aetiologies
are needed to further clarify this situation.
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